Search Results - "Mattes, Raphael"

Loss of KDM6A confers drug resistance in acute myeloid leukemia by Stief, Sophie M., Hanneforth, Anna-Li, Weser, Sabrina, Mattes, Raphael, Carlet, Michela, Liu, Wen-Hsin, Bartoschek, Michael D., Domínguez Moreno, Helena, Oettle, Matthias, Kempf, Julia, Vick, Binje, Ksienzyk, Bianka, Tizazu, Belay, Rothenberg-Thurley, Maja, Quentmeier, Hilmar, Hiddemann, Wolfgang, Vosberg, Sebastian, Greif, Philipp A., Metzeler, Klaus H., Schotta, Gunnar, Bultmann, Sebastian, Jeremias, Irmela, Leonhardt, Heinrich, Spiekermann, Karsten

“…Acute myeloid leukemia (AML) is an aggressive hematologic neoplasm resulting from the malignant transformation of myeloid progenitors. Despite intensive…”
Get full text

Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML by Kempf, Julia M., Weser, Sabrina, Bartoschek, Michael D., Metzeler, Klaus H., Vick, Binje, Herold, Tobias, Völse, Kerstin, Mattes, Raphael, Scholz, Manuela, Wange, Lucas E., Festini, Moreno, Ugur, Enes, Roas, Maike, Weigert, Oliver, Bultmann, Sebastian, Leonhardt, Heinrich, Schotta, Gunnar, Hiddemann, Wolfgang, Jeremias, Irmela, Spiekermann, Karsten

“…Chemotherapy resistance is the main impediment in the treatment of acute myeloid leukaemia (AML). Despite rapid advances, the various mechanisms inducing…”
Get full text

Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients by Greif, Philipp A, Hartmann, Luise, Vosberg, Sebastian, Stief, Sophie M, Mattes, Raphael, Hellmann, Ines, Metzeler, Klaus H, Herold, Tobias, Bamopoulos, Stefanos A, Kerbs, Paul, Jurinovic, Vindi, Schumacher, Daniela, Pastore, Friederike, Bräundl, Kathrin, Zellmeier, Evelyn, Ksienzyk, Bianka, Konstandin, Nikola P, Schneider, Stephanie, Graf, Alexander, Krebs, Stefan, Blum, Helmut, Neumann, Martin, Baldus, Claudia D, Bohlander, Stefan K, Wolf, Stephan, Görlich, Dennis, Berdel, Wolfgang E, Wörmann, Bernhard J, Hiddemann, Wolfgang, Spiekermann, Karsten

“…To study mechanisms of therapy resistance and disease progression, we analyzed the evolution of cytogenetically normal acute myeloid leukemia (CN-AML) based on…”
Get full text

Loss of KDM6A Confers Drug Resistance in Acute Myeloid Leukemia by Stief, Sophie M., Hanneforth, Anna-Li, Mattes, Raphael, Weser, Sabrina, Vick, Binje, Bartoschek, Michael D., Domínguez Moreno, Helena, Liu, Wen-Hsin, Ksienzyk, Bianka, Rothenberg-Thurley, Maja, Quentmeier, Hilmar, Hiddemann, Wolfgang, Metzeler, Klaus H., Schotta, Gunnar, Bultmann, Sebastian, Jeremias, Irmela, Leonhardt, Heinrich, Spiekermann, Karsten

“…Acute myeloid leukemia (AML) is an aggressive hematologic cancer resulting from the malignant transformation of myeloid progenitors. Despite intensive…”
Get full text

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study by Wimmer, Thomas, Mattes, Raphael, Stemmler, Hans-Joachim, Hauck, Fabian, Schulze-Koops, Hendrik, Stecher, Stephanie-Susanne, Starck, Michael, Wendtner, Clemens-Martin, Bojko, Peter, Hentrich, Marcus, Nickel, Katharina E., Götze, Katharina S., Bassermann, Florian, von Bergwelt-Baildon, Michael, Spiekermann, Karsten

“…•sCD25 appears to be a valuable adverse prognostic parameter in adult patients with HLH.•The outcome of adult patients with HLH with underlying malignancies is…”
Get full text